PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsAbdominal abscess
MeSH D018784 - abdominal abscess
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000038:Abscess
$
Success rate
D018784: 
Abdominal abscess
$
Success rate
D008100:Liver abscess
0 Companies
0 Drugs
Success rate
D013369:Subphrenic abscess
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
PfizerAnidulafungin Ecalta  2007-09-20   
Vicuron PharmaceuticalsAnidulafungin Eraxis  2006-02-17   
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
18%
2/11
Phase 3
29%
4/14
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Merck & Co
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use